Announcements
- Certara to Participate in the Jefferies Global Healthcare Conference
- Certara Appoints New Chief Human Resources Officer & General Counsel
- Certara Reports First Quarter 2024 Financial Results
- Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform
- Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare Conference
- Certara Reports Fourth Quarter 2023 Financial Results
- Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference
- Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies
- Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development
- Certara Reports Third Quarter 2023 Financial Results
More ▼
Key statistics
As of last trade, Certara Inc (700:BER) traded at 13.91, 23.05% above the 52 week low of 11.30 set on Nov 01, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 13.92 |
---|---|
High | 13.92 |
Low | 13.91 |
Bid | 13.43 |
Offer | 14.38 |
Previous close | 13.85 |
Average volume | 178.75 |
---|---|
Shares outstanding | 160.84m |
Free float | 119.65m |
P/E (TTM) | -- |
Market cap | 2.39bn USD |
EPS (TTM) | -0.3857 USD |
Data delayed at least 15 minutes, as of Jun 17 2024 09:10 BST.
More ▼